IFabric has issued details of its testing results about the efficacy of Protx2 treated fabrics for inactivating an additional Human Coronavirus, type 229E. The company has informed that testing, done by an internationally recognised, independent laboratory in the US, established its efficacy in inactivating the virus both at 10 minutes and one hour.

IFabric said that efficacy testing of Protx2 treated fabric against this additional Human Coronavirus, type 229E, was carried out by an internationally recognised, independent laboratory in the United States, to establish its ability to inactivate the virus at time points of 10 minutes and one hour. The laboratory reported that the treated fabrics demonstrated a greater than 99 per cent reduction in active viral loads on the tested fabrics at each of the two time points. This supplements prior testing to establish the efficacy of Protx2 treated fabrics against the SARS-CoV-2 Human Coronavirus, which causes the COVID-19 disease.

“Continued confirmation of Protx2’s broad spectrum antiviral efficacy is an important milestone. This additional data forms part of our ongoing strategy to provide textiles with greater levels of protection against viruses and bacteria,” stated Giancarlo Beevis, president and CEO of iFabric subsidiary Intelligent Fabric Technologies - North America (IFTNA).

“This new data will aid ITFNA in its mission to create the new standard in protective textiles and help in the struggle to reduce the risk and speed of contamination and transmission around the world,” added Beevis.